No Data
No Data
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged
Syros (SYRS) Falls 62% on Phase II Leukemia Study Termination
Sector Update: Health Care Stocks Rise Late Afternoon
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
Top Midday Decliners